Live from the NIH registry
Studies recruiting near Bonita Springs right now
Top 25 of 311 recruiting studies, sorted by proximity — each links to its official registry page
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
544 — Fort Myers, Florida (18.7 mi)
· Sponsor: Corcept Therapeutics
A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
Advanced Solid Tumors
Phase 2
Interventional 14 participants sought
Florida Cancer Specialists - Fort Myers — Fort Myers, Florida (18.7 mi)
· Sponsor: Amgen
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Obesity, Overweight
Phase 3
Interventional 300 participants sought
Essence MD Research — Naples, Florida (14.8 mi)
· Sponsor: Novo Nordisk A/S
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction, Concentric Hypertrophy
N/A
Interventional 105 participants sought
NCH Heart Institute — Naples, Florida (14.8 mi)
· Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
Vulvar Diseases, HPV Infection
Phase 2
Interventional 27 participants sought
Florida Gynecologic Oncology — Fort Myers, Florida (18.7 mi)
· Sponsor: Frantz Viral Therapeutics, LLC
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
Parkinson's Disease
Phase 1
Interventional 124 participants sought
Aqualane Clinical Research — Naples, Florida (14.8 mi)
· Sponsor: Prevail Therapeutics
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Florida Cancer Specialists - South ( Site 7004) — Fort Myers, Florida (18.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (18.7 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
GenesisCare USA - FGO — Fort Myers, Florida (18.7 mi)
· Sponsor: NRG Oncology
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (18.7 mi)
· Sponsor: Children's Oncology Group
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1165 — Fort Myers, Florida (18.7 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Florida Cancer Specialists - South — Fort Myers, Florida (18.7 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
Florida Cancer Specialists - South ( Site 7003) — Fort Myers, Florida (18.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
AMI Cardiogenic Shock
N/A
Observational 350 participants sought
NCH Rooney Heart Institute — Naples, Florida (14.8 mi)
· Sponsor: Abiomed Inc.
Patients With Congenital Myasthenic Syndrome Will be Treated With Umbilical or Placental Derived Mesenchymal Stem Cell Exosome Solution
Congenital Myasthenic Syndrome
Phase 1
Interventional 20 participants sought
Prodromos Stem Cell Institute — Naples, Florida (14.8 mi)
· Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (18.7 mi)
· Sponsor: Children's Oncology Group
LMN-201 for Prevention of C. Difficile Infection Recurrence
Clostridioides Difficile Infection
Phase 2, Phase 3
Interventional 375 participants sought
GI PROS Research — Naples, Florida (14.8 mi)
· Sponsor: Lumen Bioscience, Inc.
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Fort Myers, FL Investigative Site 10076 — Fort Myers, Florida (18.7 mi)
· Sponsor: Colorado Prevention Center
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Naples, Florida (14.8 mi)
· Sponsor: Akero Therapeutics, Inc
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 961 participants sought
GSK Investigational Site — Naples, Florida (14.8 mi)
· Sponsor: GlaxoSmithKline
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Schizophrenia, Schizoaffective Disorder
Phase 4
Interventional 100 participants sought
Neurocrine Clinical Site — Bonita Springs, Florida (1.2 mi)
· Sponsor: Neurocrine Biosciences
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 12 — Fort Myers, Florida (18.7 mi)
· Sponsor: Merus B.V.
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 300 participants sought
AMR Fort Myers (The Clinical Study Center) — Fort Myers, Florida (18.7 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
AMR Fort Myers (The Clinical Study Center) — Fort Myers, Florida (18.7 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Florida Cancer Specialists South — Fort Myers, Florida (18.7 mi)
· Sponsor: Janssen Research & Development, LLC